[go: up one dir, main page]

MX2008002021A - Metodos y composiciones para suavizar tejidos nasales y orales. - Google Patents

Metodos y composiciones para suavizar tejidos nasales y orales.

Info

Publication number
MX2008002021A
MX2008002021A MX2008002021A MX2008002021A MX2008002021A MX 2008002021 A MX2008002021 A MX 2008002021A MX 2008002021 A MX2008002021 A MX 2008002021A MX 2008002021 A MX2008002021 A MX 2008002021A MX 2008002021 A MX2008002021 A MX 2008002021A
Authority
MX
Mexico
Prior art keywords
compositions
nasal tissues
methods
soothing
oral
Prior art date
Application number
MX2008002021A
Other languages
English (en)
Inventor
Siobhan Mary Keenan
Jenny Elizabeth Bermin
Kristofer Tonstrom
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2008002021A publication Critical patent/MX2008002021A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se provee el uso de un agente de salivacion en la preparacion de un medicamento para suavizar los tejidos orales o nasales irritados. Tambien se proveen las composiciones que comprenden un agente de salivacion y un agente refrescante. El uso y las composiciones provistas en la presente proveen una mayor suavidad y un mayor alivio a los tejidos orales o nasales irritados.
MX2008002021A 2005-08-12 2006-08-03 Metodos y composiciones para suavizar tejidos nasales y orales. MX2008002021A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05017601 2005-08-12
EP06116917A EP1764097B1 (en) 2005-08-12 2006-07-10 Methods and compositions for soothing oral and nasal tissues
PCT/US2006/030527 WO2007021603A2 (en) 2005-08-12 2006-08-03 Methods and compositions for soothing oral and nasal tissues

Publications (1)

Publication Number Publication Date
MX2008002021A true MX2008002021A (es) 2008-03-25

Family

ID=37758065

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002021A MX2008002021A (es) 2005-08-12 2006-08-03 Metodos y composiciones para suavizar tejidos nasales y orales.

Country Status (9)

Country Link
EP (1) EP1764097B1 (es)
JP (1) JP2009504651A (es)
AU (1) AU2006280168A1 (es)
BR (1) BRPI0614587A2 (es)
CA (1) CA2618895A1 (es)
MX (1) MX2008002021A (es)
PL (1) PL1764097T3 (es)
RU (1) RU2008103172A (es)
WO (1) WO2007021603A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2730280B1 (en) 2012-11-08 2018-05-09 Symrise AG A menthane carboxamide for the treatment of skin inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10253331A1 (de) * 2002-11-14 2004-06-03 Symrise Gmbh & Co. Kg Verwendung von trans-Pellitori als Aromastoff
US7329767B2 (en) * 2003-10-03 2008-02-12 International Flavors & Fragrances Inc. Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof

Also Published As

Publication number Publication date
EP1764097B1 (en) 2011-03-16
WO2007021603A3 (en) 2007-07-05
JP2009504651A (ja) 2009-02-05
AU2006280168A1 (en) 2007-02-22
WO2007021603A2 (en) 2007-02-22
CA2618895A1 (en) 2007-02-22
EP1764097A1 (en) 2007-03-21
RU2008103172A (ru) 2009-09-20
BRPI0614587A2 (pt) 2011-04-05
PL1764097T3 (pl) 2011-08-31

Similar Documents

Publication Publication Date Title
IL190150A0 (en) New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
TW200612987A (en) Combination treatment for non-hematologic malignancies
SI1673104T1 (sl) Dostava terapevtskih spojin moĹľganom in drugim tkivom
MX2009011997A (es) Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos.
EP1638605A4 (en) DISTRIBUTION OF THERAPEUTIC COMPOUNDS TO THE BRAIN AND OTHER TISSUE
SE0101387D0 (sv) Novel compounds
SE0401342D0 (sv) Therapeutic compounds
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
SE0402762D0 (sv) Indazole sulphonamide derivatives
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005053719A3 (en) Compositions for the treatment of diseases of the oral cavity and upper respiratory tract
EP1952809A3 (en) Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SG152257A1 (en) Topical preparation containing ambroxol
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
UA86741C2 (ru) Амброксол для лечения боли в полости рта и глотки
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
MX2008002021A (es) Metodos y composiciones para suavizar tejidos nasales y orales.
GB0606015D0 (en) therapeutic agents
GEP20125638B (en) Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease
WO2006121521A3 (en) Soft tissue implants, anti-scarring agents, and therapeutic compositions